Shares of Revolution Medicines (RVMD) are up $23.05, or 29%, to $102.90 after The Wall Street Journal reported that AbbVie (ABBV) is in advanced talks to buy the cancer-drug maker.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD: